| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia [E. A. S., M. R. H., C. A. F.], and Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine [K. S.], Philadelphia, Pennsylvania 19104, and Pediatric Hematology/Oncology, Cooperative Health Group of Puget Sound, Seattle, Washington 98112 [P. H., R. L.]
We demonstrated a germline p53 replication error in two generations of a Li-Fraumeni family affected with liposarcoma, adrenocortical carcinoma, and osteosarcoma. The trinucleotide repeat mutation changed 5'-AGT GTG GTG GTG-3' at codons 215218 to 5'-AGT TGG TTG GTG GTG-3'. The predicted protein would be elongated by one amino acid (val216
trp leu) without a change in charge. Detection of p53 in the adrenal tumor by immunostaining suggested that the mutant protein was expressed. Persistence of the mutation in the germline may suggest a defect in DNA repair in the family member first affected. This is the first report where germline transmission of replication-damaged p53 trinucleotide repeats is associated with the Li-Fraumeni syndrome.
1 Supported by American Cancer Society IRG 135-M and Leukemia Society of America Special Fellowship (both to C. A. F.) and by NIH Training Grant 5-T35-HD-07217 (to E. A. S.).
3 To whom requests for reprints should be addressed, at Division of Oncology, Room 9093, Children's Hospital of Philadelphia, 324 South 34th Street, Philadelphia, PA 19104.
Received 3/30/95. Accepted 6/16/95.
This article has been cited by other articles:
![]() |
D. G. B. Leonard, L. B. Travis, K. Addya, G. M. Dores, E. J. Holowaty, K. Bergfeldt, D. Malkin, B. A. Kohler, C. F. Lynch, T. Wiklund, et al. p53 Mutations in Leukemia and Myelodysplastic Syndrome after Ovarian Cancer Clin. Cancer Res., May 1, 2002; 8(5): 973 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Nichols, D. Malkin, J. E. Garber, J. F. Fraumeni Jr., and F. P. Li Germ-line p53 Mutations Predispose to a Wide Spectrum of Early-onset Cancers Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 83 - 87. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |